Personalized Medicine Discovery May Improve Hospitals’ Sepsis Outcomes
German-based diagnostics company identifies biomarkers that could help reduce sepsis costs, suggests basing a precision medicine initiative in the hospital ICU.
German-based diagnostics company identifies biomarkers that could help reduce sepsis costs, suggests basing a precision medicine initiative in the hospital ICU.
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations
Why gene editing technology CRISPR is getting attention as a potential testing solution amid the coronavirus pandemic.
“Don’t underestimate the importance of aligning the interests of different stakeholders,” says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
De-identified data that hospitals and health systems share with big tech can sometimes be used to identify patients. As these types of deals grow, full transparency with patients is key…
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in…
When a health network CEO considers how to introduce a precision medicine service into clinical care, the up-front costs can be substantial, but the potential rewards are significant …